Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date09/30/16 → 09/29/18

    Funding

    • Quark Pharmaceuticals Incorporated: $32,962.50